Galectin Therapeutics Insider Sale Signals Liquidity Needs, Not Strategic Pivot
Insider sale at Galectin Therapeutics reveals CEO liquidity needs and raises questions on future strategy, but the company’s key clinical milestones and competitive landscape remain critical for its valuation and growth.
4 minutes to read